EP2030981
Efnasambönd fyrir meltikornaensímhindrun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.5.2005EP published:
9.7.2014EP application number:
08164241.5
EP translation filed:
29.9.2014Grant published:
15.10.2014EPO information:
European Patent Register
Max expiry date:
8.5.2025Expiry date:
8.5.2020
Title:
Compounds for proteasome enzyme inhibition
Timeline
Today
9.5.2005EP application
9.7.2014EP Publication
29.9.2014Translation submitted
15.10.2014Registration published
8.5.2020Expires
Owner
Name:
Onyx Therapeutics, Inc.Address:
249 East Grand Avenue, 94080, South San Francisco, CA, US
Inventor
Name:
Smyth, Mark S.Address:
San Mateo, CA, US
Name:
Laidig, Guy J.Address:
Menlo Park, CA, US
Name:
Borchardt, Ronald T.Address:
Lawrence, KS, US
Name:
Bunin, Barry A.Address:
Belmont, CA, US
Name:
Crews, Craig M.Address:
New Haven, CT, US
Name:
Musser, John H.Address:
San Carlos, CA, US
Name:
Shenk, Kevin D.Address:
Palo Alto, CA, US
Name:
Radel, Peggy A.Address:
Berkeley, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
569885 PDate:
10.5.2004Country:
US
Number:
610040 PDate:
14.9.2004Country:
US
Number:
634366 PDate:
7.12.2004Country:
US
Classification
Categories:
C07K 5/087, C07K 5/08, A61K 38/06, C07K 5/062, C07K 5/078, C07D 303/32, C07D 409/12, C07K 5/027, C07D 413/12, A61K 31/335
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 9.4.2015
Expires: 8.5.2016
Payer: Árnason Faktor
Number: 12
Paid: 10.5.2016
Expires: 8.5.2017
Payer: Árnason Faktor
Number: 13
Paid: 10.4.2017
Expires: 8.5.2018
Payer: Árnason Faktor
Number: 14
Paid: 9.4.2018
Expires: 8.5.2019
Payer: Árnason Faktor
Number: 15
Paid: 5.4.2019
Expires: 8.5.2020
Payer: Árnason Faktor